Request for Covid-19 Impact Assessment of this Report
The United States Metabotropic Glutamate Receptor 1 market is expected at value of US$ million in 2021 and grow at approximately % CAGR during review period. China constitutes a % market for the global Metabotropic Glutamate Receptor 1 market, reaching US$ million by the year 2028. As for the Europe Metabotropic Glutamate Receptor 1 landscape, Germany is projected to reach US$ million by 2028 trailing a CAGR of % over the forecast period. In APAC, the growth rates of other notable markets (Japan and South Korea) are projected to be at % and % respectively for the next 5-year period.
Global main Metabotropic Glutamate Receptor 1 players cover Aevi Genomic Medicine Inc, Biohaven Pharmaceutical Holding Company Ltd, , and , etc. In terms of revenue, the global largest two companies occupy a share nearly % in 2021.
This report presents a comprehensive overview, market shares, and growth opportunities of Metabotropic Glutamate Receptor 1 market by product type, application, key manufacturers and key regions and countries.
Segmentation by type: breakdown data from 2017 to 2022, in Section 2.3; and forecast to 2028 in section 12.6
FC-311
JBPOS-0101
VU-0467558
Others
Segmentation by application: breakdown data from 2017 to 2022, in Section 2.4; and forecast to 2028 in section 12.7.
Depression
DiGeorge Syndrome
Infantile Spasm
Others
This report also splits the market by region: Breakdown data in Chapter 4, 5, 6, 7 and 8.
Americas
United States
Canada
Mexico
Brazil
APAC
China
Japan
Korea
Southeast Asia
India
Australia
Europe
Germany
France
UK
Italy
Russia
Middle East & Africa
Egypt
South Africa
Israel
Turkey
GCC Countries
The report also presents the market competition landscape and a corresponding detailed analysis of the prominent manufacturers in this market, include
Aevi Genomic Medicine Inc
Biohaven Pharmaceutical Holding Company Ltd
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
2 Executive Summary
2.1 World Market Overview
2.1.1 Global Metabotropic Glutamate Receptor 1 Annual Sales 2017-2028
2.1.2 World Current & Future Analysis for Metabotropic Glutamate Receptor 1 by Geographic Region, 2017, 2022 & 2028
2.1.3 World Current & Future Analysis for Metabotropic Glutamate Receptor 1 by Country/Region, 2017, 2022 & 2028
2.2 Metabotropic Glutamate Receptor 1 Segment by Type
2.2.1 FC-311
2.2.2 JBPOS-0101
2.2.3 VU-0467558
2.2.4 Others
2.3 Metabotropic Glutamate Receptor 1 Sales by Type
2.3.1 Global Metabotropic Glutamate Receptor 1 Sales Market Share by Type (2017-2022)
2.3.2 Global Metabotropic Glutamate Receptor 1 Revenue and Market Share by Type (2017-2022)
2.3.3 Global Metabotropic Glutamate Receptor 1 Sale Price by Type (2017-2022)
2.4 Metabotropic Glutamate Receptor 1 Segment by Application
2.4.1 Depression
2.4.2 DiGeorge Syndrome
2.4.3 Infantile Spasm
2.4.4 Others
2.5 Metabotropic Glutamate Receptor 1 Sales by Application
2.5.1 Global Metabotropic Glutamate Receptor 1 Sale Market Share by Application (2017-2022)
2.5.2 Global Metabotropic Glutamate Receptor 1 Revenue and Market Share by Application (2017-2022)
2.5.3 Global Metabotropic Glutamate Receptor 1 Sale Price by Application (2017-2022)
3 Global Metabotropic Glutamate Receptor 1 by Company
3.1 Global Metabotropic Glutamate Receptor 1 Breakdown Data by Company
3.1.1 Global Metabotropic Glutamate Receptor 1 Annual Sales by Company (2020-2022)
3.1.2 Global Metabotropic Glutamate Receptor 1 Sales Market Share by Company (2020-2022)
3.2 Global Metabotropic Glutamate Receptor 1 Annual Revenue by Company (2020-2022)
3.2.1 Global Metabotropic Glutamate Receptor 1 Revenue by Company (2020-2022)
3.2.2 Global Metabotropic Glutamate Receptor 1 Revenue Market Share by Company (2020-2022)
3.3 Global Metabotropic Glutamate Receptor 1 Sale Price by Company
3.4 Key Manufacturers Metabotropic Glutamate Receptor 1 Producing Area Distribution, Sales Area, Product Type
3.4.1 Key Manufacturers Metabotropic Glutamate Receptor 1 Product Location Distribution
3.4.2 Players Metabotropic Glutamate Receptor 1 Products Offered
3.5 Market Concentration Rate Analysis
3.5.1 Competition Landscape Analysis
3.5.2 Concentration Ratio (CR3, CR5 and CR10) & (2020-2022)
3.6 New Products and Potential Entrants
3.7 Mergers & Acquisitions, Expansion
4 World Historic Review for Metabotropic Glutamate Receptor 1 by Geographic Region
4.1 World Historic Metabotropic Glutamate Receptor 1 Market Size by Geographic Region (2017-2022)
4.1.1 Global Metabotropic Glutamate Receptor 1 Annual Sales by Geographic Region (2017-2022)
4.1.2 Global Metabotropic Glutamate Receptor 1 Annual Revenue by Geographic Region
4.2 World Historic Metabotropic Glutamate Receptor 1 Market Size by Country/Region (2017-2022)
4.2.1 Global Metabotropic Glutamate Receptor 1 Annual Sales by Country/Region (2017-2022)
4.2.2 Global Metabotropic Glutamate Receptor 1 Annual Revenue by Country/Region
4.3 Americas Metabotropic Glutamate Receptor 1 Sales Growth
4.4 APAC Metabotropic Glutamate Receptor 1 Sales Growth
4.5 Europe Metabotropic Glutamate Receptor 1 Sales Growth
4.6 Middle East & Africa Metabotropic Glutamate Receptor 1 Sales Growth
5 Americas
5.1 Americas Metabotropic Glutamate Receptor 1 Sales by Country
5.1.1 Americas Metabotropic Glutamate Receptor 1 Sales by Country (2017-2022)
5.1.2 Americas Metabotropic Glutamate Receptor 1 Revenue by Country (2017-2022)
5.2 Americas Metabotropic Glutamate Receptor 1 Sales by Type
5.3 Americas Metabotropic Glutamate Receptor 1 Sales by Application
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC Metabotropic Glutamate Receptor 1 Sales by Region
6.1.1 APAC Metabotropic Glutamate Receptor 1 Sales by Region (2017-2022)
6.1.2 APAC Metabotropic Glutamate Receptor 1 Revenue by Region (2017-2022)
6.2 APAC Metabotropic Glutamate Receptor 1 Sales by Type
6.3 APAC Metabotropic Glutamate Receptor 1 Sales by Application
6.4 China
6.5 Japan
6.6 South Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
6.10 China Taiwan
7 Europe
7.1 Europe Metabotropic Glutamate Receptor 1 by Country
7.1.1 Europe Metabotropic Glutamate Receptor 1 Sales by Country (2017-2022)
7.1.2 Europe Metabotropic Glutamate Receptor 1 Revenue by Country (2017-2022)
7.2 Europe Metabotropic Glutamate Receptor 1 Sales by Type
7.3 Europe Metabotropic Glutamate Receptor 1 Sales by Application
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 Middle East & Africa
8.1 Middle East & Africa Metabotropic Glutamate Receptor 1 by Country
8.1.1 Middle East & Africa Metabotropic Glutamate Receptor 1 Sales by Country (2017-2022)
8.1.2 Middle East & Africa Metabotropic Glutamate Receptor 1 Revenue by Country (2017-2022)
8.2 Middle East & Africa Metabotropic Glutamate Receptor 1 Sales by Type
8.3 Middle East & Africa Metabotropic Glutamate Receptor 1 Sales by Application
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 Market Drivers, Challenges and Trends
9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends
10 Manufacturing Cost Structure Analysis
10.1 Raw Material and Suppliers
10.2 Manufacturing Cost Structure Analysis of Metabotropic Glutamate Receptor 1
10.3 Manufacturing Process Analysis of Metabotropic Glutamate Receptor 1
10.4 Industry Chain Structure of Metabotropic Glutamate Receptor 1
11 Marketing, Distributors and Customer
11.1 Sales Channel
11.1.1 Direct Channels
11.1.2 Indirect Channels
11.2 Metabotropic Glutamate Receptor 1 Distributors
11.3 Metabotropic Glutamate Receptor 1 Customer
12 World Forecast Review for Metabotropic Glutamate Receptor 1 by Geographic Region
12.1 Global Metabotropic Glutamate Receptor 1 Market Size Forecast by Region
12.1.1 Global Metabotropic Glutamate Receptor 1 Forecast by Region (2023-2028)
12.1.2 Global Metabotropic Glutamate Receptor 1 Annual Revenue Forecast by Region (2023-2028)
12.2 Americas Forecast by Country
12.3 APAC Forecast by Region
12.4 Europe Forecast by Country
12.5 Middle East & Africa Forecast by Country
12.6 Global Metabotropic Glutamate Receptor 1 Forecast by Type
12.7 Global Metabotropic Glutamate Receptor 1 Forecast by Application
13 Key Players Analysis
13.1 Aevi Genomic Medicine Inc
13.1.1 Aevi Genomic Medicine Inc Company Information
13.1.2 Aevi Genomic Medicine Inc Metabotropic Glutamate Receptor 1 Product Offered
13.1.3 Aevi Genomic Medicine Inc Metabotropic Glutamate Receptor 1 Sales, Revenue, Price and Gross Margin (2020-2022)
13.1.4 Aevi Genomic Medicine Inc Main Business Overview
13.1.5 Aevi Genomic Medicine Inc Latest Developments
14 Research Findings and Conclusion
Table 1. Metabotropic Glutamate Receptor 1 Annual Sales CAGR by Geographic Region (2017, 2022 & 2028) & ($ millions)
Table 2. Metabotropic Glutamate Receptor 1 Annual Sales CAGR by Country/Region (2017, 2022 & 2028) & ($ millions)
Table 3. Major Players of FC-311
Table 4. Major Players of JBPOS-0101
Table 5. Major Players of VU-0467558
Table 6. Major Players of Others
Table 7. Global Metabotropic Glutamate Receptor 1 Sales by Type (2017-2022) & (K Pcs)
Table 8. Global Metabotropic Glutamate Receptor 1 Sales Market Share by Type (2017-2022)
Table 9. Global Metabotropic Glutamate Receptor 1 Revenue by Type (2017-2022) & ($ million)
Table 10. Global Metabotropic Glutamate Receptor 1 Revenue Market Share by Type (2017-2022)
Table 11. Global Metabotropic Glutamate Receptor 1 Sale Price by Type (2017-2022) & (USD/Pcs)
Table 12. Global Metabotropic Glutamate Receptor 1 Sales by Application (2017-2022) & (K Pcs)
Table 13. Global Metabotropic Glutamate Receptor 1 Sales Market Share by Application (2017-2022)
Table 14. Global Metabotropic Glutamate Receptor 1 Revenue by Application (2017-2022)
Table 15. Global Metabotropic Glutamate Receptor 1 Revenue Market Share by Application (2017-2022)
Table 16. Global Metabotropic Glutamate Receptor 1 Sale Price by Application (2017-2022) & (USD/Pcs)
Table 17. Global Metabotropic Glutamate Receptor 1 Sales by Company (2020-2022) & (K Pcs)
Table 18. Global Metabotropic Glutamate Receptor 1 Sales Market Share by Company (2020-2022)
Table 19. Global Metabotropic Glutamate Receptor 1 Revenue by Company (2020-2022) ($ Millions)
Table 20. Global Metabotropic Glutamate Receptor 1 Revenue Market Share by Company (2020-2022)
Table 21. Global Metabotropic Glutamate Receptor 1 Sale Price by Company (2020-2022) & (USD/Pcs)
Table 22. Key Manufacturers Metabotropic Glutamate Receptor 1 Producing Area Distribution and Sales Area
Table 23. Players Metabotropic Glutamate Receptor 1 Products Offered
Table 24. Metabotropic Glutamate Receptor 1 Concentration Ratio (CR3, CR5 and CR10) & (2020-2022)
Table 25. New Products and Potential Entrants
Table 26. Mergers & Acquisitions, Expansion
Table 27. Global Metabotropic Glutamate Receptor 1 Sales by Geographic Region (2017-2022) & (K Pcs)
Table 28. Global Metabotropic Glutamate Receptor 1 Sales Market Share Geographic Region (2017-2022)
Table 29. Global Metabotropic Glutamate Receptor 1 Revenue by Geographic Region (2017-2022) & ($ millions)
Table 30. Global Metabotropic Glutamate Receptor 1 Revenue Market Share by Geographic Region (2017-2022)
Table 31. Global Metabotropic Glutamate Receptor 1 Sales by Country/Region (2017-2022) & (K Pcs)
Table 32. Global Metabotropic Glutamate Receptor 1 Sales Market Share by Country/Region (2017-2022)
Table 33. Global Metabotropic Glutamate Receptor 1 Revenue by Country/Region (2017-2022) & ($ millions)
Table 34. Global Metabotropic Glutamate Receptor 1 Revenue Market Share by Country/Region (2017-2022)
Table 35. Americas Metabotropic Glutamate Receptor 1 Sales by Country (2017-2022) & (K Pcs)
Table 36. Americas Metabotropic Glutamate Receptor 1 Sales Market Share by Country (2017-2022)
Table 37. Americas Metabotropic Glutamate Receptor 1 Revenue by Country (2017-2022) & ($ Millions)
Table 38. Americas Metabotropic Glutamate Receptor 1 Revenue Market Share by Country (2017-2022)
Table 39. Americas Metabotropic Glutamate Receptor 1 Sales by Type (2017-2022) & (K Pcs)
Table 40. Americas Metabotropic Glutamate Receptor 1 Sales Market Share by Type (2017-2022)
Table 41. Americas Metabotropic Glutamate Receptor 1 Sales by Application (2017-2022) & (K Pcs)
Table 42. Americas Metabotropic Glutamate Receptor 1 Sales Market Share by Application (2017-2022)
Table 43. APAC Metabotropic Glutamate Receptor 1 Sales by Region (2017-2022) & (K Pcs)
Table 44. APAC Metabotropic Glutamate Receptor 1 Sales Market Share by Region (2017-2022)
Table 45. APAC Metabotropic Glutamate Receptor 1 Revenue by Region (2017-2022) & ($ Millions)
Table 46. APAC Metabotropic Glutamate Receptor 1 Revenue Market Share by Region (2017-2022)
Table 47. APAC Metabotropic Glutamate Receptor 1 Sales by Type (2017-2022) & (K Pcs)
Table 48. APAC Metabotropic Glutamate Receptor 1 Sales Market Share by Type (2017-2022)
Table 49. APAC Metabotropic Glutamate Receptor 1 Sales by Application (2017-2022) & (K Pcs)
Table 50. APAC Metabotropic Glutamate Receptor 1 Sales Market Share by Application (2017-2022)
Table 51. Europe Metabotropic Glutamate Receptor 1 Sales by Country (2017-2022) & (K Pcs)
Table 52. Europe Metabotropic Glutamate Receptor 1 Sales Market Share by Country (2017-2022)
Table 53. Europe Metabotropic Glutamate Receptor 1 Revenue by Country (2017-2022) & ($ Millions)
Table 54. Europe Metabotropic Glutamate Receptor 1 Revenue Market Share by Country (2017-2022)
Table 55. Europe Metabotropic Glutamate Receptor 1 Sales by Type (2017-2022) & (K Pcs)
Table 56. Europe Metabotropic Glutamate Receptor 1 Sales Market Share by Type (2017-2022)
Table 57. Europe Metabotropic Glutamate Receptor 1 Sales by Application (2017-2022) & (K Pcs)
Table 58. Europe Metabotropic Glutamate Receptor 1 Sales Market Share by Application (2017-2022)
Table 59. Middle East & Africa Metabotropic Glutamate Receptor 1 Sales by Country (2017-2022) & (K Pcs)
Table 60. Middle East & Africa Metabotropic Glutamate Receptor 1 Sales Market Share by Country (2017-2022)
Table 61. Middle East & Africa Metabotropic Glutamate Receptor 1 Revenue by Country (2017-2022) & ($ Millions)
Table 62. Middle East & Africa Metabotropic Glutamate Receptor 1 Revenue Market Share by Country (2017-2022)
Table 63. Middle East & Africa Metabotropic Glutamate Receptor 1 Sales by Type (2017-2022) & (K Pcs)
Table 64. Middle East & Africa Metabotropic Glutamate Receptor 1 Sales Market Share by Type (2017-2022)
Table 65. Middle East & Africa Metabotropic Glutamate Receptor 1 Sales by Application (2017-2022) & (K Pcs)
Table 66. Middle East & Africa Metabotropic Glutamate Receptor 1 Sales Market Share by Application (2017-2022)
Table 67. Key Market Drivers & Growth Opportunities of Metabotropic Glutamate Receptor 1
Table 68. Key Market Challenges & Risks of Metabotropic Glutamate Receptor 1
Table 69. Key Industry Trends of Metabotropic Glutamate Receptor 1
Table 70. Metabotropic Glutamate Receptor 1 Raw Material
Table 71. Key Suppliers of Raw Materials
Table 72. Metabotropic Glutamate Receptor 1 Distributors List
Table 73. Metabotropic Glutamate Receptor 1 Customer List
Table 74. Global Metabotropic Glutamate Receptor 1 Sales Forecast by Region (2023-2028) & (K Pcs)
Table 75. Global Metabotropic Glutamate Receptor 1 Sales Market Forecast by Region
Table 76. Global Metabotropic Glutamate Receptor 1 Revenue Forecast by Region (2023-2028) & ($ millions)
Table 77. Global Metabotropic Glutamate Receptor 1 Revenue Market Share Forecast by Region (2023-2028)
Table 78. Americas Metabotropic Glutamate Receptor 1 Sales Forecast by Country (2023-2028) & (K Pcs)
Table 79. Americas Metabotropic Glutamate Receptor 1 Revenue Forecast by Country (2023-2028) & ($ millions)
Table 80. APAC Metabotropic Glutamate Receptor 1 Sales Forecast by Region (2023-2028) & (K Pcs)
Table 81. APAC Metabotropic Glutamate Receptor 1 Revenue Forecast by Region (2023-2028) & ($ millions)
Table 82. Europe Metabotropic Glutamate Receptor 1 Sales Forecast by Country (2023-2028) & (K Pcs)
Table 83. Europe Metabotropic Glutamate Receptor 1 Revenue Forecast by Country (2023-2028) & ($ millions)
Table 84. Middle East & Africa Metabotropic Glutamate Receptor 1 Sales Forecast by Country (2023-2028) & (K Pcs)
Table 85. Middle East & Africa Metabotropic Glutamate Receptor 1 Revenue Forecast by Country (2023-2028) & ($ millions)
Table 86. Global Metabotropic Glutamate Receptor 1 Sales Forecast by Type (2023-2028) & (K Pcs)
Table 87. Global Metabotropic Glutamate Receptor 1 Sales Market Share Forecast by Type (2023-2028)
Table 88. Global Metabotropic Glutamate Receptor 1 Revenue Forecast by Type (2023-2028) & ($ Millions)
Table 89. Global Metabotropic Glutamate Receptor 1 Revenue Market Share Forecast by Type (2023-2028)
Table 90. Global Metabotropic Glutamate Receptor 1 Sales Forecast by Application (2023-2028) & (K Pcs)
Table 91. Global Metabotropic Glutamate Receptor 1 Sales Market Share Forecast by Application (2023-2028)
Table 92. Global Metabotropic Glutamate Receptor 1 Revenue Forecast by Application (2023-2028) & ($ Millions)
Table 93. Global Metabotropic Glutamate Receptor 1 Revenue Market Share Forecast by Application (2023-2028)
Table 94. Aevi Genomic Medicine Inc Basic Information, Metabotropic Glutamate Receptor 1 Manufacturing Base, Sales Area and Its Competitors
Table 95. Aevi Genomic Medicine Inc Metabotropic Glutamate Receptor 1 Product Offered
Table 96. Aevi Genomic Medicine Inc Metabotropic Glutamate Receptor 1 Sales (K Pcs), Revenue ($ Million), Price (USD/Pcs) and Gross Margin (2020-2022)
Table 97. Aevi Genomic Medicine Inc Main Business
Table 98. Aevi Genomic Medicine Inc Latest Developments
Table 99. Biohaven Pharmaceutical Holding Company Ltd Basic Information, Metabotropic Glutamate Receptor 1 Manufacturing Base, Sales Area and Its Competitors
Table 100. Biohaven Pharmaceutical Holding Company Ltd Metabotropic Glutamate Receptor 1 Product Offered
Table 101. Biohaven Pharmaceutical Holding Company Ltd Metabotropic Glutamate Receptor 1 Sales (K Pcs), Revenue ($ Million), Price (USD/Pcs) and Gross Margin (2020-2022)
Table 102. Biohaven Pharmaceutical Holding Company Ltd Main Business
Table 103. Biohaven Pharmaceutical Holding Company Ltd Latest Developments
List of Figures
Figure 1. Picture of Metabotropic Glutamate Receptor 1
Figure 2. Metabotropic Glutamate Receptor 1 Report Years Considered
Figure 3. Research Objectives
Figure 4. Research Methodology
Figure 5. Research Process and Data Source
Figure 6. Global Metabotropic Glutamate Receptor 1 Sales Growth Rate 2017-2028 (K Pcs)
Figure 7. Global Metabotropic Glutamate Receptor 1 Revenue Growth Rate 2017-2028 ($ Millions)
Figure 8. Metabotropic Glutamate Receptor 1 Sales by Region (2021 & 2028) & ($ millions)
Figure 9. Product Picture of FC-311
Figure 10. Product Picture of JBPOS-0101
Figure 11. Product Picture of VU-0467558
Figure 12. Product Picture of Others
Figure 13. Global Metabotropic Glutamate Receptor 1 Sales Market Share by Type in 2021
Figure 14. Global Metabotropic Glutamate Receptor 1 Revenue Market Share by Type (2017-2022)
Figure 15. Metabotropic Glutamate Receptor 1 Consumed in Depression
Figure 16. Global Metabotropic Glutamate Receptor 1 Market: Depression (2017-2022) & (K Pcs)
Figure 17. Metabotropic Glutamate Receptor 1 Consumed in DiGeorge Syndrome
Figure 18. Global Metabotropic Glutamate Receptor 1 Market: DiGeorge Syndrome (2017-2022) & (K Pcs)
Figure 19. Metabotropic Glutamate Receptor 1 Consumed in Infantile Spasm
Figure 20. Global Metabotropic Glutamate Receptor 1 Market: Infantile Spasm (2017-2022) & (K Pcs)
Figure 21. Metabotropic Glutamate Receptor 1 Consumed in Others
Figure 22. Global Metabotropic Glutamate Receptor 1 Market: Others (2017-2022) & (K Pcs)
Figure 23. Global Metabotropic Glutamate Receptor 1 Sales Market Share by Application (2017-2022)
Figure 24. Global Metabotropic Glutamate Receptor 1 Revenue Market Share by Application in 2021
Figure 25. Metabotropic Glutamate Receptor 1 Revenue Market by Company in 2021 ($ Million)
Figure 26. Global Metabotropic Glutamate Receptor 1 Revenue Market Share by Company in 2021
Figure 27. Global Metabotropic Glutamate Receptor 1 Sales Market Share by Geographic Region (2017-2022)
Figure 28. Global Metabotropic Glutamate Receptor 1 Revenue Market Share by Geographic Region in 2021
Figure 29. Global Metabotropic Glutamate Receptor 1 Sales Market Share by Region (2017-2022)
Figure 30. Global Metabotropic Glutamate Receptor 1 Revenue Market Share by Country/Region in 2021
Figure 31. Americas Metabotropic Glutamate Receptor 1 Sales 2017-2022 (K Pcs)
Figure 32. Americas Metabotropic Glutamate Receptor 1 Revenue 2017-2022 ($ Millions)
Figure 33. APAC Metabotropic Glutamate Receptor 1 Sales 2017-2022 (K Pcs)
Figure 34. APAC Metabotropic Glutamate Receptor 1 Revenue 2017-2022 ($ Millions)
Figure 35. Europe Metabotropic Glutamate Receptor 1 Sales 2017-2022 (K Pcs)
Figure 36. Europe Metabotropic Glutamate Receptor 1 Revenue 2017-2022 ($ Millions)
Figure 37. Middle East & Africa Metabotropic Glutamate Receptor 1 Sales 2017-2022 (K Pcs)
Figure 38. Middle East & Africa Metabotropic Glutamate Receptor 1 Revenue 2017-2022 ($ Millions)
Figure 39. Americas Metabotropic Glutamate Receptor 1 Sales Market Share by Country in 2021
Figure 40. Americas Metabotropic Glutamate Receptor 1 Revenue Market Share by Country in 2021
Figure 41. United States Metabotropic Glutamate Receptor 1 Revenue Growth 2017-2022 ($ Millions)
Figure 42. Canada Metabotropic Glutamate Receptor 1 Revenue Growth 2017-2022 ($ Millions)
Figure 43. Mexico Metabotropic Glutamate Receptor 1 Revenue Growth 2017-2022 ($ Millions)
Figure 44. Brazil Metabotropic Glutamate Receptor 1 Revenue Growth 2017-2022 ($ Millions)
Figure 45. APAC Metabotropic Glutamate Receptor 1 Sales Market Share by Region in 2021
Figure 46. APAC Metabotropic Glutamate Receptor 1 Revenue Market Share by Regions in 2021
Figure 47. China Metabotropic Glutamate Receptor 1 Revenue Growth 2017-2022 ($ Millions)
Figure 48. Japan Metabotropic Glutamate Receptor 1 Revenue Growth 2017-2022 ($ Millions)
Figure 49. South Korea Metabotropic Glutamate Receptor 1 Revenue Growth 2017-2022 ($ Millions)
Figure 50. Southeast Asia Metabotropic Glutamate Receptor 1 Revenue Growth 2017-2022 ($ Millions)
Figure 51. India Metabotropic Glutamate Receptor 1 Revenue Growth 2017-2022 ($ Millions)
Figure 52. Australia Metabotropic Glutamate Receptor 1 Revenue Growth 2017-2022 ($ Millions)
Figure 53. Europe Metabotropic Glutamate Receptor 1 Sales Market Share by Country in 2021
Figure 54. Europe Metabotropic Glutamate Receptor 1 Revenue Market Share by Country in 2021
Figure 55. Germany Metabotropic Glutamate Receptor 1 Revenue Growth 2017-2022 ($ Millions)
Figure 56. France Metabotropic Glutamate Receptor 1 Revenue Growth 2017-2022 ($ Millions)
Figure 57. UK Metabotropic Glutamate Receptor 1 Revenue Growth 2017-2022 ($ Millions)
Figure 58. Italy Metabotropic Glutamate Receptor 1 Revenue Growth 2017-2022 ($ Millions)
Figure 59. Russia Metabotropic Glutamate Receptor 1 Revenue Growth 2017-2022 ($ Millions)
Figure 60. Middle East & Africa Metabotropic Glutamate Receptor 1 Sales Market Share by Country in 2021
Figure 61. Middle East & Africa Metabotropic Glutamate Receptor 1 Revenue Market Share by Country in 2021
Figure 62. Egypt Metabotropic Glutamate Receptor 1 Revenue Growth 2017-2022 ($ Millions)
Figure 63. South Africa Metabotropic Glutamate Receptor 1 Revenue Growth 2017-2022 ($ Millions)
Figure 64. Israel Metabotropic Glutamate Receptor 1 Revenue Growth 2017-2022 ($ Millions)
Figure 65. Turkey Metabotropic Glutamate Receptor 1 Revenue Growth 2017-2022 ($ Millions)
Figure 66. GCC Country Metabotropic Glutamate Receptor 1 Revenue Growth 2017-2022 ($ Millions)
Figure 67. Manufacturing Cost Structure Analysis of Metabotropic Glutamate Receptor 1 in 2021
Figure 68. Manufacturing Process Analysis of Metabotropic Glutamate Receptor 1
Figure 69. Industry Chain Structure of Metabotropic Glutamate Receptor 1
Figure 70. Channels of Distribution
Figure 71. Distributors Profiles
The United States pneumococcal & meningococcal vaccines market is set to surpass US$ 7.5 Million by the year end of 2025. “United States Pneumococcal & Meningococcal Vaccines Market by Company Profile, Deals Type, Brand Analysis, Share, Key Trends & Opportunities to 2025” presents an in–depth assessment of the United States pneumococcal & meningococcal vaccines market dynamics, opportunitie...
The global human immunodeficiency virus (HIV) drugs market size is expected to surpass US$ 30 billion by 2025. “Global Human Immunodeficiency Virus (HIV) Drugs Market 2019 – 2025: Top 22 Drugs Analysis, Key Trends, Players and Forecasts” presents an in-depth assessment of the global human immunodeficiency virus (HIV) drugs market dynamics, opportunities, future roadmap, competitive landscap...
The global 50 blockbuster drugs market size is estimated to reach a value of US$ 292 billion by 2025. ‘’Global Blockbuster Drugs Market 2015 - 2025: Top 50 Drugs Analysis, Deal Trends, Players and Forecasts” presents an in-depth assessment of the global blockbuster drugs market dynamics, opportunities, future roadmap, competitive landscape and discusses major trends. The report offers the m...